Main Menu

Alumni profiles

We are proud of the successes of all of our former students and strive to continue to include them as part of the ICR community as they move forward in their careers. Of those that graduated between 2010 and 2018 that completed a non-clinical research degree, 85% went directly into active scientific research roles, 88% of which were in academia and 12% in industry all over the world. Meet some of our alumni below, and read about their experience of studying at the ICR and their career journeys so far.

Heba Saliem

Heba Saliem

Completion date: PhD (non-clinical) 2014

Dr Heba Saliem completed her PhD at The Institute of Cancer Research in 2014. She was recently awarded a Sir Henry Wellcome Postdoctoral Fellowship to develop new computational methods to interpret data from large-scale imaging studies.

Read more

Fiona Rowan

Fiona Rowan

Completion date: PhD (non-clinical) 2014

Dr Fiona Rowan was awarded her PhD in Biology and Chemistry at The Institute of Cancer Research in 2014. She is now an early-career academic scientist, pursuing her goal to one day lead her own research lab.

 

Read more

Dan Lloyd

Dan Lloyd

Completion date: PhD (non-clinical) 1998

Professor Dan Lloyd completed his PhD at The Institute of Cancer Research in 1998. Remaining within academia, he is now the Deputy Head of School of Biosciences at the University of Kent. His research into DNA damage, and how this relates to cancer and its treatment, underpins varied teaching, research and managerial responsibilities.

Read more

Ana-Teresa Maia

Ana-Teresa Maia

Completion date: PhD (non-clinical) 2003

Dr Ana-Teresa Maia completed her PhD at The Institute of Cancer Research in 2003. She is now the Vice-Director of the Centre for Biomedical Research at the University of Algarve.

Read more

Oliver Rausch

Oliver Rausch

Completion date: PhD (non-clinical) 1997

Dr Oliver Rausch completed his PhD at The Institute of Cancer Research in 1997. He is now Vice President Research & Development at Storm Therapeutics Ltd, a spin-out company from Cambridge University that is developing potential new cancer treatments.

Read more

Isla Furlong

Isla Furlong

Completion date: PhD (non-clinical) 1997

Dr Isla Furlong completed her PhD at The Institute of Cancer Research in 1997. She now works as a patent attorney, specialising in advising start-up companies and academic institutes on biopharmaceutical patent issues.

Read more

Trevor McMillan

Trevor McMillan

Completion date: PhD (non-clinical) 1984

Professor Trevor McMillan was awarded a PhD in Biophysics at The Institute of Cancer Research in 1984. He is now the Vice-Chancellor of the University of Keele.

Read more

John Amuasi

John Amuasi

Completion date: PhD 1982 (non-clinical)

Professor John Amuasi has led a distinguished career in medical physics at the Ghana Atomic Energy Commission (GAEC) for over 40 years. In 1976, he came to the UK to carry out his MSc and PhD at the ICR.

Read more

Timothy Yap

Timothy Yap

Completion date: PhD (clinical) 2010, Postgraduate Diploma in Oncology 2013

Dr Yap undertook a PhD in Molecular Pharmacology in the Division of Cancer Therapeutics from February 2007 to August 2010. As a Medical Oncology Specialist Registrar, he also undertook a Postgraduate Diploma in Oncology at The Institute of Cancer Research, which he completed in October 2013.

Read more

Susana Banerjee

Susana Banerjee

Completion date: PhD (clinical) 2009, Postgraduate Diploma in Oncology 2010

Dr Susana Banerjee completed her PhD and second year of her Postgraduate Diploma in Oncology at the ICR, and is now a Consultant Medical Oncologist at the Royal Marsden. She continues her research collaborating with the ICR and is the lead for clinical and translational trials in gynaecological cancers.

Read more

Tim Eisen

Tim Eisen

Completion date: PhD (clinical) 1995

Professor Tim Eisen completed his PhD in 1995 at the Marie Curie Research Institute in association with the Institute of Cancer Research. He is currently Head of Oncology Early Clinical Development at AstraZeneca and Professor of Medical Oncology at the University of Cambridge. His special interests are the treatment of melanoma, lung and kidney cancers.

Read more
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.